Trump just slapped 100% tariffs on patented pharmaceuticals. Not generic drugs — those are conveniently exempt. Patented ones. The cancer treatments, the specialty biologics, the drugs that exist because no generic alternative does yet. It kicks in July 31st for some companies and September 29th for the rest — right in time for your prescription costs to spike as the weather cools.
The national security justification is real, in writing, in the presidential proclamation. The idea that your rheumatoid arthritis medication threatens American military readiness is the kind of logic that sounds like satire until you remember we’re fully in it. Drug companies that cut a deal with HHS on pricing get a zero-tariff rate. Everyone else pays double. So the administration is using sick people as leverage to negotiate with pharmaceutical executives, which is somehow the charitable reading of what’s happening here.
Trump ran on lowering drug prices. You can measure the gap between that promise and this policy in dollars — specifically the extra ones you’ll owe at the pharmacy counter starting in fall.